Chevron Corporation
CVX
$228.23
-1.63%
Chevron Corporation is a fully integrated energy major whose operations span worldwide exploration and production (3.7 million net oil-equivalent barrels per day in 2025), a 1.8 million barrel-per-day refining and downstream network concentrated in the U.S. and Asia, and 10.6 billion barrels of proved reserves, placing it as the second-largest U.S. oil company behind ExxonMobil. Its competitive identity rests on scale, balance-sheet conservatism, and an integrated model that cushions upstream commodity swings with downstream cash generation, plus a shareholder-return framework anchored by a roughly 4.5% dividend yield. The current investor narrative is dominated by portfolio reshaping: Chevron is divesting Hess Midstream at a $3-4 billion loss to cut Bakken midstream costs roughly in half and simplify the balance sheet, while simultaneously committing $7 billion to a Venezuela expansion that management argues could double low-cost production if political risk cooperates. These moves, layered on a sharp post-Q2 earnings re-rating and a 49% year-to-date rally, have investors debating whether the stock is now pricing in a durable oil-price and capital-discipline regime or has run ahead of fundamentals.…
CVX
Chevron Corporation
$228.23
Related headlines
Investment Opinion: Should I buy CVX Today?
Rating: Hold. The thesis is that Chevron is a high-quality integrated major whose Q2 2026 earnings inflection and fortress balance sheet are real, but whose 49% YTD rally has already captured the re-rating, leaving the shares at the $230.67 average analyst target with roughly -1% implied upside and a consensus rating of 1.72 (buy) that is more bullish in tone than in expected return.
The supporting evidence is genuinely strong: forward PE of 14.84x against trailing 22.92x implies 35% earnings growth to the $13.93 consensus EPS; Q2 2026 revenue grew 51.43% YoY to $67.20 billion with net income of $12.07 billion; TTM free cash flow of $27.01 billion covers the 4.52% dividend yield; and debt-to-equity of 0.219 is best-in-class. Price-to-book of 1.51x sits near the low end of its 1.43-2.23x historical range, and EV/EBITDA of 7.70x is typical for integrated majors — so on asset-based measures the stock is not expensive.
The risks that could invalidate the thesis are margin normalization (Q2's 45.52% gross margin versus 30.41% TTM), the 103.7% payout ratio, and the wide $175-$253 analyst target range reflecting genuine disagreement. This Hold would upgrade to Buy on a pullback toward the $200-210 area that restores 10%+ upside to the average target, or if Q3 confirms gross margins holding above 40%; it would downgrade to Sell if gross margins fall below 30% or if forward EPS estimates are cut below $12. Verdict: fairly valued relative to history and peers — not overvalued, but no longer undervalued after the rally.
Sign up to view all
CVX 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Chevron Corporation's 12-month outlook, with a consensus price target around $232.50 and implied upside of +1.9% versus the current price.
Average Target
$232.50
0 analysts
Implied Upside
+1.9%
vs. current price
Analyst Count
—
covering this stock
Price Range
$175 - $272
Analyst target range
Coverage is deep and constructive: 24 analysts follow Chevron with a consensus recommendation of "buy" (mean rating 1.72 on a 1-5 scale where 1 is strong buy), and the average target price of $230.67 sits essentially at the current $233.21 — implying roughly -1% downside, meaning the stock has already caught up to consensus. That is a meaningful signal: after a 49% year-to-date run, the shares are trading at or slightly above the average analyst's fair value, so further gains likely require estimate revisions rather than multiple re-rating. The consensus leans bullish in rating but neutral in implied return, a classic setup for consolidation unless new catalysts emerge. The target range is wide, from $175 to $253, a spread of about 45% of the current price that signals genuine disagreement about the oil-price and margin outlook. The high target of $253 (about 8.5% above the current price) likely assumes sustained strong crack spreads, successful Venezuela ramp-up, and continued earnings beats against the $13.93 consensus EPS; the low target of $175 (about 25% below) prices in margin normalization, commodity weakness, or disappointment on the Hess Midstream restructuring. Institutional ratings show a stable-to-positive tilt — Morgan Stanley, Wells Fargo, Piper Sandler, BMO, and HSBC all maintain Overweight/Buy/Outperform ratings through September 2026, while TD Cowen and Barclays stay at Hold/Equal Weight and Bernstein at Market Perform — with no downgrades in the recent tape, suggesting the bull case is intact but the easy money has been made.
Bulls vs Bears: CVX Investment Factors
The bull case currently has stronger evidence: the Q2 2026 earnings inflection (EPS $6.13 vs. $1.45 a year earlier), fortress balance sheet (D/E 0.219), $27.01 billion TTM free cash flow, and 35.83 points of one-year relative strength are hard, verifiable facts, whereas the bear case rests largely on the sustainability question. The single most important tension is whether Q2's 45.52% gross margin represents a new baseline or a crack-spread spike — if it is durable, the 14.84x forward PE is genuinely cheap and the stock can grind higher; if it normalizes toward the 30.41% TTM level, the $13.93 consensus EPS is at risk and the stock is fully valued at best. Secondary tension comes from the stock sitting at 99.8% of its 52-week range with essentially zero implied upside to the average analyst target, meaning the easy money from the re-rating has been made. The Venezuela commitment and Hess Midstream write-off add a layer of capital-allocation uncertainty that could swing sentiment either way.
Bullish
- Forward PE of 14.8x is reasonable: The stock trades at 22.92x trailing earnings but only 14.84x forward earnings, a 35% compression that implies the market expects EPS to grow from the depressed trailing base toward the $13.93 consensus. For a mega-cap integrated with a 4.52% dividend yield, 14.84x forward is not a stretched multiple and leaves room for earnings-driven upside.
- Q2 2026 earnings power inflected sharply: Q2 2026 net income of $12.07 billion (EPS $6.13) versus $2.49 billion a year earlier, on revenue up 51.43% YoY to $67.20 billion, shows the Hess integration and strong crack spreads are translating directly to the bottom line. Gross margin of 45.52% and operating margin of 31.96% in the quarter dwarf the TTM figures of 30.41% and 9.04%.
- Balance sheet and cash generation are fortress-like: Debt-to-equity of just 0.219 and a current ratio of 1.155 underpin one of the strongest balance sheets among majors, while TTM free cash flow of $27.01 billion comfortably funds the $3.50 billion quarterly dividend and buybacks. First-half 2026 operating cash flow of $22.63 billion against only $4.54 billion of capex leaves ample discretionary cash.
- Massive relative strength and momentum leadership: CVX is up 48.96% over one year and 49.59% YTD, outperforming SPY by 35.83 and 38.14 percentage points respectively — rare leadership for a mega-cap integrated. The 13.48% one-month gain versus SPY's -1.02% shows momentum is accelerating, not fading, and beta of 0.523 means this leadership came with roughly half the market's volatility.
Bearish
- Stock has caught up to analyst fair value: At $233.21, CVX trades essentially at the $230.67 average analyst target — roughly -1% implied return — meaning the 49% YTD rally has already priced in consensus expectations. Further gains now require estimate revisions rather than multiple re-rating, a classic setup for consolidation.
- Q2 margin spike may not be sustainable: The gap between Q2 2026's 45.52% gross margin and the TTM's 30.41% is the central debate; Q1 2026 gross margin was only 9.58% and Q2 2025 was 29.69%. If Q2 reflected a crack-spread spike rather than a new baseline, the $13.93 consensus EPS may prove optimistic and the 14.84x forward PE is illusory.
- Payout ratio of 103.7% flags dividend risk: The dividend consumes more than 100% of trailing EPS, which is only sustainable because of the depressed trailing earnings base. If forward EPS of $13.93 does not materialize, the 4.52% yield — a core part of the bull case — would come under pressure or require balance-sheet funding.
- Pressing against 52-week high with 21.5% drawdown history: At $233.21 the stock sits at 99.8% of its $146.49-$233.74 range, with only $0.53 to resistance, and has already shown a 21.53% max drawdown over the trailing year. Late-stage momentum where the 1-month gain (13.48%) exceeds the 3-month gain (19.72%) is prone to sharp air pockets.
CVX Technical Analysis
Chevron is in a powerful, sustained uptrend: the stock is up 48.96% over the past year and 49.59% year-to-date, and at $233.21 it sits at roughly 99.8% of its 52-week range of $146.49 to $233.74 — essentially pressing against its high. That positioning signals strong momentum and trend confirmation, but also leaves little margin for error; a stock at the top of its range with a 21.53% max drawdown over the trailing year is prone to sharp air pockets when sentiment shifts. Relative strength reinforces the trend: CVX has outperformed SPY by 35.83 percentage points over one year and 38.14 points year-to-date, a rare degree of leadership for a mega-cap integrated. Short-term momentum is accelerating rather than fading: the stock gained 13.48% in the past month versus a 1.02% decline for SPY (14.50 points of relative strength), and 19.72% over three months against SPY's 2.85%. The 2.88% single-day jump on the latest close to $233.21, on volume of about 8.14 million shares, suggests buyers are chasing the breakout rather than distributing, and the 1-month gain exceeding the 3-month gain implies the move is steepening — a hallmark of late-stage momentum that warrants tighter risk controls. Key levels are clear: resistance is the 52-week high at $233.74, just $0.53 above the current price, so a decisive close above that level would confirm a fresh breakout and likely invite trend-following flows; support sits at the 52-week low of $146.49, with intermediate support implied by the June-July consolidation around $165-175. Beta of 0.523 means the stock is roughly half as volatile as the market, which supports larger position sizing on a risk-adjusted basis, but the elevated absolute price and near-high positioning argue for scaling in rather than chasing, and a short ratio of 2.38 indicates no meaningful short-squeeze fuel behind the rally.
Beta
0.52
0.52x market volatility
Max Drawdown
-21.5%
Largest decline past year
52-Week Range
$146-$234
Price range past year
Annual Return
+47.0%
Cumulative gain past year
| Period | CVX Return | S&P 500 |
|---|---|---|
| 1m | +11.6% | -0.2% |
| 3m | +19.0% | +5.5% |
| 6m | +18.1% | +7.1% |
| 1y | +47.0% | +12.3% |
| ytd | +46.4% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CVX Fundamental Analysis
Revenue has inflected sharply upward: Q2 2026 revenue reached $67.20 billion, up 51.43% year-over-year from $44.38 billion in Q2 2025, a dramatic acceleration from the roughly $45.8-48.2 billion quarterly run-rate seen through 2025. The segment mix shows downstream as the larger revenue contributor at $49.65 billion versus upstream at $17.53 billion, meaning refining and marketing — not crude production — is currently driving the top line, consistent with strong crack spreads and the Hess integration expanding volumes. Net income of $12.07 billion in Q2 2026 (EPS $6.13 diluted) versus $2.49 billion a year earlier confirms the growth is translating to the bottom line, though investors should note the prior-year base was depressed and the sequential jump from Q1 2026's $2.21 billion net income (EPS $1.12) is unusually large, raising the question of how much is sustainable versus one-time. Profitability metrics are healthy but volatile: Q2 2026 gross margin was 45.52% and operating margin 31.96%, far above the 9.58% gross margin reported in Q1 2026 and the 29.69% gross margin in Q2 2025, while the TTM figures in the valuation dataset show a more normalized 30.41% gross margin, 9.04% operating margin, and 6.67% net margin. The gap between the stellar Q2 quarter and the muted TTM averages is the central fundamental debate — if Q2 margins represent a new baseline, the stock is cheap; if they were a crack-spread spike, earnings estimates of $13.93 for the year may prove optimistic. The balance sheet is a source of strength: debt-to-equity of just 0.219, a current ratio of 1.155, and TTM free cash flow of $27.01 billion against $22.63 billion of first-half 2026 operating cash flow and $4.54 billion of capex. ROE of 6.60% and ROA of 5.86% look modest for the valuation, reflecting a low-return commodity business, but the company comfortably funds its $3.50 billion quarterly dividend and buybacks internally — the payout ratio of 103.7% on trailing EPS is a yellow flag that should normalize sharply if forward EPS of $13.93 materializes.
Quarterly Revenue
$67.2B
2026-06
Revenue YoY Growth
+51.4%
YoY Comparison
Gross Margin
45.5%
Latest Quarter
Free Cash Flow
$27.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CVX Overvalued?
Because Chevron is solidly profitable (Q2 2026 net income of $12.07 billion, TTM EPS positive), the PE ratio is the appropriate primary metric. The stock trades at 22.92x trailing earnings but only 14.84x forward earnings — a 35% compression that implies the market expects earnings to grow substantially, consistent with the $13.93 consensus EPS estimate versus the depressed trailing figure. The forward multiple of 14.84x is reasonable for a mega-cap integrated and suggests the recent rally is being validated by earnings expectations rather than pure multiple expansion, though the trailing PE of 22.92x versus the historical Q2 2026 reading of 6.76x shows how dramatically the earnings base has swung quarter to quarter. On peer comparison, the provided dataset does not include an explicit industry-average multiple, so a precise premium/discount cannot be quantified; however, the 1.51x price-to-book, 1.53x price-to-sales, 7.70x EV/EBITDA, and 2.35x EV/sales all sit in a range typical of integrated oil majors, and the 4.52% dividend yield is well above the sector's historical norm, suggesting the stock is not expensive relative to its own asset base. Historical context is instructive: Chevron's PE ranged from roughly 6x to 46x over the past several years, with the 22.92x trailing reading in the upper-middle of that band, while price-to-book of 1.51x is near the low end of its 1.43-2.23x historical range — a mixed signal that says the market is paying a normal earnings multiple for a historically cheap asset base, which is consistent with a value re-rating rather than a bubble.
PE
22.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 6x~30x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
7.7x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings durability and the dividend. The 103.7% payout ratio on trailing EPS means the $3.50 billion quarterly dividend is currently funded from cash flow rather than earnings, which works only because TTM free cash flow is $27.01 billion — but if Q2's 45.52% gross margin reverts toward the 30.41% TTM level, the cushion narrows quickly. Revenue is heavily concentrated in downstream at $49.65 billion versus $17.53 billion upstream, making the top line unusually dependent on refining crack spreads, and the sequential swing from Q1 2026 net income of $2.21 billion to Q2's $12.07 billion demonstrates extreme quarter-to-quarter earnings volatility. ROE of 6.60% and ROA of 5.86% are modest for the valuation and reflect the low-return nature of the commodity business.
Market and competitive risks are dominated by valuation compression and commodity sensitivity. At 22.92x trailing earnings the stock sits in the upper-middle of its historical 6x-46x band, and with the average analyst target of $230.67 essentially at the current $233.21 price, there is no valuation cushion if estimates disappoint. Beta of 0.523 provides some insulation from broad market moves, but the stock's 48.96% one-year gain versus SPY's 13.13% means it has become a crowded momentum trade — the 2.88% single-day jump on 8.14 million shares suggests buyers are chasing rather than accumulating on weakness. The $7 billion Venezuela commitment introduces political and operational risk that could force write-downs, while the $3-4 billion Hess Midstream loss shows the company is willing to absorb near-term hits for strategic repositioning.
The worst-case scenario is a crack-spread normalization combined with an oil-price pullback: Q2 margins revert toward the 30.41% TTM gross margin, the $13.93 consensus EPS is cut, and the forward PE re-rates from 14.84x toward the historical low end. In that chain, the stock could retrace to the analyst low target of $175, about -25% from $233.21, and in a severe commodity downturn toward the 52-week low of $146.49, roughly -37%. The 21.53% max drawdown already experienced over the trailing year shows this magnitude of decline is realistic, not theoretical, and a stock at 99.8% of its 52-week range has no technical support until the $165-175 June-July consolidation zone.
FAQ
The most severe risk is margin normalization: Q2 2026's 45.52% gross margin versus the 30.41% TTM level means a reversion would undermine the $13.93 consensus EPS and the 14.84x forward multiple, potentially sending the stock toward the $175 analyst low target. Second is dividend coverage, with a 103.7% payout ratio on trailing EPS that depends on the earnings recovery materializing. Third is capital-allocation and political risk from the $7 billion Venezuela commitment and the $3-4 billion Hess Midstream write-off, which could produce further charges. Fourth is momentum and valuation risk: the stock is at 99.8% of its 52-week range with a 21.53% max drawdown history, and beta of 0.523 offers only partial protection if energy sector rotation accelerates. Ranked by severity: margin normalization, dividend coverage, political/capital allocation, then momentum unwind.
The 12-month outlook has three scenarios. The base case (50% probability) targets $220-240, assuming margins settle in the 30-35% range, EPS lands near the $13.93 consensus, and the stock consolidates around the $230.67 average analyst target with the 4.52% dividend providing total return. The bull case (25%) targets $245-253, requiring gross margins above 40%, a Venezuela ramp, and upward EPS revisions toward the $253 high target. The bear case (25%) targets $175-195, driven by crack-spread compression, an oil price decline below $70, and EPS cuts toward the $175 low target. The base case is most likely, and its key assumption is that Q2's margin spike partially normalizes but stays above the 30.41% TTM level, keeping forward EPS near consensus.
CVX looks fairly valued rather than clearly cheap or expensive. The trailing PE of 22.92x sits in the upper-middle of its historical 6x-46x band, but the forward PE of 14.84x implies 35% earnings growth to the $13.93 consensus and is reasonable for a mega-cap integrated. Price-to-book of 1.51x is near the low end of its 1.43-2.23x historical range, and EV/EBITDA of 7.70x and price-to-sales of 1.53x are typical for the sector, so the market is paying a normal earnings multiple for a historically cheap asset base. The 4.52% dividend yield is well above the sector's historical norm and supports the valuation. What the market is pricing in is a durable margin regime — if Q2's 45.52% gross margin holds, the stock is modestly undervalued; if margins revert to 30.41%, it is fully valued.
From a risk/reward perspective, CVX is a reasonable but no longer compelling buy at $233.21. The stock trades essentially at the $230.67 average analyst target, implying roughly -1% upside, after a 49.59% YTD rally that has left it at 99.8% of its 52-week range. The fundamental case is solid — 14.84x forward earnings, $27.01 billion TTM free cash flow, 0.219 debt-to-equity, and a 4.52% dividend yield — but the biggest downside risk is margin normalization from Q2's 45.52% gross margin toward the 30.41% TTM level, which could take the stock to the $175 analyst low target, about -25%. It is a good buy for income investors comfortable with commodity cyclicality who can scale in on pullbacks toward $200-210, and less attractive for momentum buyers chasing at the high.
CVX is better suited to long-term holding than short-term trading. It is a mature, fully integrated major with 10.6 billion barrels of proved reserves, a 4.52% dividend yield, and beta of 0.523, which makes it a lower-volatility income and value holding rather than a momentum vehicle. However, the stock is currently at 99.8% of its 52-week range after a 49.59% YTD gain, with a 21.53% max drawdown over the trailing year, so short-term entry at these levels carries meaningful air-pocket risk. Earnings visibility is moderate — quarterly net income swung from $2.21 billion in Q1 2026 to $12.07 billion in Q2 — which argues against trading around reports. A suggested minimum holding period is 3-5 years to capture the dividend, the Venezuela and Hess integration payoff, and a full commodity cycle, with new positions scaled in on pullbacks toward $200-210 rather than chased at the high.